Drug Information

Drug General Information
Drug ID
D04AHQ
Former ID
DIB005975
Drug Name
LY3009120
Indication Cancer [ICD9: 140-229; ICD10:C00-C96] Phase 1 [524570]
Company
Lilly
Target and Pathway
Target(s) Raf protein kinase Target Info Modulator
References
Ref 524570ClinicalTrials.gov (NCT02014116) A Study of LY3009120 in Participants With Advanced Cancer or Cancer That Has Spread to Other Parts of Their Body. U.S. National Institutes of Health.